SCHEMBL6583342

SCHEMBL6583342

CC(C)NC(C)c1cccnc1

nearest known ligand 0.61

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.61
SMN1; SMN2 Q16637 2/20 0.50
CFTR P13569 2/20 0.48
GOPC Q9HD26 2/20 0.48
SLC6A2 P23975 1/20 0.48
SLC6A4 P31645 1/20 0.48
SLC6A3 Q01959 1/20 0.48
CYP19A1 P11511 1/20 0.43
GAA P10253 1/20 0.42
CYP17A1 P05093 1/20 0.42
CYP2C9 P11712 1/20 0.42
NAMPT P43490 1/20 0.42
ADORA2B P29275 3/20 0.40
ADORA2A P29274 1/20 0.40
LMNA P02545 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8012590 0.92 KDM4E (0.65) KDM4ESMN1; SMN2CFTRGOPCSLC6A2
SCHEMBL1487951 0.84 KDM4E (0.61) KDM4ESMN1; SMN2CFTRGOPCSLC6A2
SCHEMBL30664391 0.83 KDM4E (0.65) KDM4ESMN1; SMN2CFTRGOPCSLC6A2
SCHEMBL21836264 0.83 KDM4E (0.65) KDM4ESMN1; SMN2CFTRGOPCSLC6A2
SCHEMBL21836265 0.83 KDM4E (0.65) KDM4ESMN1; SMN2CFTRGOPCSLC6A2
SCHEMBL8013444 0.82 KDM4E (0.54) KDM4ESMN1; SMN2CFTRGOPCSLC6A2
SCHEMBL13081367 0.82 KDM4E (0.62) KDM4ESMN1; SMN2CFTRGOPCSLC6A2
SCHEMBL2373412 0.82 KDM4E (0.62) KDM4ESMN1; SMN2CFTRGOPCSLC6A2
SCHEMBL18945578 0.80 KDM4E (0.61) KDM4ESMN1; SMN2CFTRGOPCSLC6A2
SCHEMBL6220536 0.80 KDM4E (0.61) KDM4ESMN1; SMN2CFTRGOPCSLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0871615-B1 SUBSTITUTED PYRIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS MODULATORS OF ACETYLCHOLINE RECEPTORS MERCK & CO INC (US) 2004-07-14 EP disclosed
US-6194581-B1 FOR TREATMENT OF DYSFUNCTION OF THE CENTRAL OR AUTONOMIC NERVOUS SYSTEMS INCLUDING DEMENTIA, COGNITIVE DISORDERS, NEURODEGENERATIVE DISORDERS, EXTRAPYRAMIDAL DISORDERS, CONVULSIVE DISORDERS, CARDIOVASCULAR DISORDERS, PAIN MERCK & CO., INC. 2001-02-27 US disclosed
US-5852041-A Substituted pyridines useful as modulators of acethylcholine receptors SIBIA NEUROSCIENCES, INC. (US) 1998-12-22 US disclosed
EP-0871615-A1 SUBSTITUTED PYRIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS MODULATORS OF ACETYLCHOLINE RECEPTORS SIBIA NEUROSCIENCES, INC. (US) 1998-10-21 EP disclosed
US-5736560-A USEFUL IN THE TREATMENT OF ALZHEIMER'S AND PARKINSONS'S DISEASES SIBIA NEUROSCIENCES, INC. (US) 1998-04-07 US disclosed
US-5686473-A TREATING PARKINSON*S DISEASE, ALZHEIMER*S DISEASE, DEMENTIA AND PAIN SIBIA NEUROSCIENCES, INC. (US) 1997-11-11 US disclosed
US-5585388-A Substituted pyridines useful as modulators of acetylcholine receptors SIBIA NEUROSCIENCES, INC. (US) 1996-12-17 US disclosed
WO-1996031475-A2 SUBSTITUTED PYRIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS MODULATORS OF ACETYLCHOLINE RECEPTORS SIBIA NEUROSCIENCES, INC. (US) 1996-10-10 WO disclosed